Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| SELECTIS HEALTH, INC.GBCS · Entity 9641 | Director · PRESIDENT AND COO | March 30, 2022 | April 07, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
SELECTIS HEALTH, INC.
Report date March 30, 2022 · Filed April 07, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $7.00 · Expires 2032-03-30 | Direct | 100,000 |
Reported balance
After 2022-03-30 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-03-30 · Grant · Acquired 100,000 · Balance 100,000 |
| Common StockSEC Table I · non-derivative | Direct | 80,134 |
Reported balance
Holding disclosure · report date 2022-03-30 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 80,134 F1: Total number of shares gives effect to 2021 1 for 10 reverse stock split. |
Filing footnotes · ownership attribution and instrument terms
F1: Total number of shares gives effect to 2021 1 for 10 reverse stock split.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 30, 2022 Filed Apr 7, 2022 16:50 UTC | SELECTIS HEALTH, INC. GBCS · Entity 9641 | GrantCommon Stock Options · Derivative | 100,000 | $7.00 Strike: $7.00 | $700,000.00 |
DisclosureSEC source: 0001493152-22-009330 · ownership.xml · derivative · entry 2 Barker Christopher R. · CIK 0001838039 · Director · PRESIDENT AND COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common stock · 100,000 shares Expires 2032-03-30 Read SEC document |
| July 09, 2021 Filed Jul 13, 2021 18:35 UTC | SELECTIS HEALTH, INC. GBCS · Entity 9641 | PurchaseCommon Stock | 50,000 | $0.50 | $25,000.00 |
DisclosureSEC source: 0001493152-21-016704 · ownership.xml · nonDerivative · entry 2 Barker Christopher R. · CIK 0001838039 · Director · PRESIDENT AND COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 801,341 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.